Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Cardiac and acoustic metastases in relapsing melanoma.

Lopci E, Monti L, Balzarini L, Chiti A.

Clin Nucl Med. 2013 Feb;38(2):e85-8. doi: 10.1097/RLU.0b013e31826c0cc0.

PMID:
23334145
[PubMed - indexed for MEDLINE]
2.

The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history.

Fortnum H, O'Neill C, Taylor R, Lenthall R, Nikolopoulos T, Lightfoot G, O'Donoghue G, Mason S, Baguley D, Jones H, Mulvaney C.

Health Technol Assess. 2009 Mar;13(18):iii-iv, ix-xi, 1-154. doi: 10.3310/hta13180. Review.

PMID:
19358774
[PubMed - indexed for MEDLINE]
Free Article
3.

Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.

Isiklar I, Leeds NE, Fuller GN, Kumar AJ.

AJR Am J Roentgenol. 1995 Dec;165(6):1503-12.

PMID:
7484597
[PubMed - indexed for MEDLINE]
4.

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.

Orcurto V, Denys A, Voelter V, Schalenbourg A, Schnyder P, Zografos L, Leyvraz S, Delaloye AB, Prior JO.

Melanoma Res. 2012 Feb;22(1):63-9. doi: 10.1097/CMR.0b013e32834d3dcb.

PMID:
22027909
[PubMed - indexed for MEDLINE]
5.

The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.

Gross MW, Weber WA, Feldmann HJ, Bartenstein P, Schwaiger M, Molls M.

Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):989-95.

PMID:
9719107
[PubMed - indexed for MEDLINE]
6.

Metastatic melanoma to the heart.

Allen BC, Mohammed TL, Tan CD, Miller DV, Williamson EE, Kirsch JS.

Curr Probl Diagn Radiol. 2012 Sep-Oct;41(5):159-64. doi: 10.1067/j.cpradiol.2011.09.001. Review.

PMID:
22818836
[PubMed - indexed for MEDLINE]
7.

A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT.

Ozülker T, Ozülker F, Cicin I, Ozpaçac T.

Clin Nucl Med. 2009 Dec;34(12):948-9. doi: 10.1097/RLU.0b013e3181bed02c. No abstract available.

PMID:
20139846
[PubMed - indexed for MEDLINE]
8.

MR imaging of acoustic neuroma with high resolution fast spin echo T2-weighted sequence.

Soulié D, Cordoliani YS, Vignaud J, Cosnard G.

Eur J Radiol. 1997 Jan;24(1):61-5.

PMID:
9056152
[PubMed - indexed for MEDLINE]
9.

Magnetic resonance imaging in the investigation of sensorineural hearing loss: is contrast enhancement still necessary?

Annesley-Williams DJ, Laitt RD, Jenkins JP, Ramsden RT, Gillespie JE.

J Laryngol Otol. 2001 Jan;115(1):14-21.

PMID:
11233615
[PubMed - indexed for MEDLINE]
10.

The appearance of cardiac metastasis from squamous cell carcinoma of the lung on F-18 FDG PET/CT and post hoc PET/MRI.

Probst S, Seltzer A, Spieler B, Chachoua A, Friedman K.

Clin Nucl Med. 2011 Apr;36(4):311-2. doi: 10.1097/RLU.0b013e31820a9fd1. No abstract available.

PMID:
21368610
[PubMed - indexed for MEDLINE]
11.

Metastasis of malignant melanoma to common biliary duct demonstrated with F-18 FDG PET/CT.

Sanli Y, Ozkan G, Yegen G, Turkmen C, Mudun A.

Clin Nucl Med. 2011 Jun;36(6):470-2. doi: 10.1097/RLU.0b013e31820ade2e.

PMID:
21552029
[PubMed - indexed for MEDLINE]
12.

Role of FDG-PET in the assessment of survival prognosis in melanoma.

Pleiss C, Risse JH, Biersack HJ, Bender H.

Cancer Biother Radiopharm. 2007 Dec;22(6):740-7.

PMID:
18158764
[PubMed - indexed for MEDLINE]
13.

Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.

Stadnik TW, Everaert H, Makkat S, Sacré R, Lamote J, Bourgain C.

Eur Radiol. 2006 Oct;16(10):2153-60. Epub 2006 May 3.

PMID:
16670863
[PubMed - indexed for MEDLINE]
14.

18FDG-PET/CT assessing the absence of cell viability and excluding metastatic disease in a case of necrotic choroidal melanoma.

Romero-Aroca P, Montero-Jaime M, Intriago B, Riu F, Peña-Gonzalez KB, Almena-Garcia M.

Eur J Ophthalmol. 2012 Mar-Apr;22(2):288-92. doi: 10.5301/ejo.5000016.

PMID:
21725939
[PubMed - indexed for MEDLINE]
15.

Visceral metastases from melanoma: findings on MR imaging.

Premkumar A, Sanders L, Marincola F, Feuerstein I, Concepcion R, Schwartzentruber D.

AJR Am J Roentgenol. 1992 Feb;158(2):293-8.

PMID:
1729784
[PubMed - indexed for MEDLINE]
16.

Malignant lesions of the liver with high signal intensity on T1-weighted MR images.

Kelekis NL, Semelka RC, Woosley JT.

J Magn Reson Imaging. 1996 Mar-Apr;6(2):291-4.

PMID:
9132092
[PubMed - indexed for MEDLINE]
17.

Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT.

Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, Tiemann K, Maintz D, Scheld HH, Schober O, Weckesser M.

J Nucl Med. 2012 Jun;53(6):856-63. doi: 10.2967/jnumed.111.095364. Epub 2012 May 10.

PMID:
22577239
[PubMed - indexed for MEDLINE]
Free Article
18.

Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.

Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Nakajima T, Arisaka Y, Higuchi T, Amanuma M, Endo K.

Ann Nucl Med. 2008 Jun;22(5):395-401. doi: 10.1007/s12149-008-0128-1. Epub 2008 Jul 4.

PMID:
18600417
[PubMed - indexed for MEDLINE]
19.

Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.

Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M.

Q J Nucl Med Mol Imaging. 2004 Sep;48(3):188-97.

PMID:
15499292
[PubMed - indexed for MEDLINE]
Free Article
20.

MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.

Dong A, Dong H, Wang Y, Gong J, Lu J, Zuo C.

Clin Nucl Med. 2013 Feb;38(2):e66-73. doi: 10.1097/RLU.0b013e318266ceca.

PMID:
22996250
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk